If You Invested $2,500 in Moderna in 2019, This Is How Much You Would Have Today
It seems intuitively true that anyone who invested in Moderna (NASDAQ: MRNA) in recent years made out like a bandit thanks to the company's quickly developed coronavirus jab. As it turns out, great businesses can sometimes be bad investments, at least temporarily.
More importantly, past performance is no guarantee of future returns -- and star-studded stocks are no exception. So let's explore these concepts a bit further by figuring out how much a relatively small investment of $2,500 in Moderna a mere handful of years ago would have made you, and why the timing of your investment probably had a lot to do with how willing you were to hold on to it.
If you bought $2,500 worth of Moderna's shares at the start of January 2019, just a month after its initial public offering (IPO), you'd now have around $22,550 after experiencing ginormous gains of 801%. That's a pretty sweet investment, though there's a good chance you would have sold your shares in mid-2022 rather than holding on for longer, as that's when they were worth upwards of $75,000.
Source Fool.com
Moderna Inc. Aktie
Die Aktie ist durchaus ein Favorit unsere Community mit 21 Buy-Einschätzungen und 2 Sell-Einschätzungen.
Das von der Community festgelegte Kursziel von 129 € für Moderna Inc. bedeutet eine mögliche Steigerung um über 50% im Vergleich zu 78.79 €.
